Search

everythinglearnresearchcommunity

for

Search:↓

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Transgender men need personalized cancer care and continued testosterone therapy for well-being.

Some hormone treatments might raise breast cancer risk, while others don't seem to.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

Chemotherapy for breast cancer often causes significant and lasting hair loss.

17β-estradiol lowers polyamine oxidase levels in breast cancer cells through estrogen receptor 2.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Genetic differences affect breast cancer treatment success with tamoxifen in South African patients.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Honey and bee pollen can help reduce menopausal symptoms in breast cancer patients.

HER2-targeted or hormonal therapies improve quality of life for Sudanese breast cancer patients.

Patients and oncologists prioritize survival benefits, while payers focus on treatment costs.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Evaluate postmenopausal women with high androgen levels using medical history, physical exams, lab tests, and imaging to manage health risks.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Testosterone therapy can safely and effectively treat symptoms like low libido and fatigue in women, especially after menopause.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Testosterone replacement can help menopausal women with various symptoms, but should be used carefully and is not yet officially licensed in the UK for women.

Reporter characteristics affect detection of hair loss from cancer therapy.

Reporter characteristics affect detection of hair loss from cancer therapy.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

Oral contraceptives provide various health benefits beyond birth control, including managing menstrual issues, skin conditions, pain, and reducing the risk of certain cancers.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.